#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease
Click here to read this study in NEJM
Tag: CKD
Chronic kidney disease associated with increased risk of spontaneous intracranial hemorrhage
1. Chronic kidney disease was independently associated with an increased risk of spontaneous intracranial hemorrhage, regardless of race or ethnicity. ...
Comparisons of invasive versus conservative management in chronic kidney disease in the ISCHEMIA-CKD trials
1. Following invasive or conservative management of chronic coronary disease, patients with chronic kidney disease (CKD) stage 5 were found ...
#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis
1. This trial demonstrated noninferiority of daprodustat to darbepoetin alfa in the treatment of anemia in patients with chronic kidney ...
Risk of chronic kidney disease progression may be greater amongst patients with obstructive sleep apnea
1. This study found moderate-to-very high risk of chronic kidney disease progression was greater in patients with more severe obstructive ...
Wellness Check: Sleep
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
#VisualAbstract: Ziltivekimab antagonism of IL-6 reduces inflammation and thrombosis in patients with atherosclerotic risk factors
1. Ziltivekimab lowered high-sensitivity CRP levels, a predictor of vascular events, compared to placebo in a dose-dependent manner. 2. Thrombotic biomarkers including ...
#VisualAbstract: Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD Increases Risk of Major Cardiovascular Events and Mortality
1. Stopping renin-angiotensin system inhibition in patients with advanced chronic kidney disease was associated with higher risk of mortality, major cardiovascular ...
Outcomes associated with discontinuation of RASi in patients with chronic kidney disease
1. Stopping renin-angiotensin system inhibition in patients with advanced chronic kidney disease was associated with higher risk of mortality, major cardiovascular ...
Fixed low dose of erythropoeitin associated with similar efficacy outcomes as as titration-based dosing
1. In patients with CKD, fixed low dose of erythropoietin provides similar efficacy outcomes, such as percentage of patients requiring ...
